June 25, 2020 / 3:24 PM / 21 days ago

BRIEF-Aptevo Therapeutics Says Will Receive Royalty Payments From Pfizer Related To Sales Of A Rituximab Biosimilar Product, Ruxience

June 25 (Reuters) - Aptevo Therapeutics Inc:

* APTEVO THERAPEUTICS - WILL RECEIVE ROYALTY PAYMENTS FROM PFIZER RELATED TO SALES OF A RITUXIMAB BIOSIMILAR PRODUCT, RUXIENCE

* APTEVO THERAPEUTICS - ROYALTY TERM RUNS UNTIL SEVENTH ANNIVERSARY OF FIRST COMMERCIAL SALE OF BIOSIMILAR Source text: (bit.ly/2Z7O6bX) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below